Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Comparison of Antitumor Effects of Native and Recombinant Human Interferon-α on Non-small Cell Lung Cancer Cells (CROSBI ID 193736)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Šantak, Goran ; Šantak, Maja ; Forčić, Dubravko Comparison of Antitumor Effects of Native and Recombinant Human Interferon-α on Non-small Cell Lung Cancer Cells // Anticancer Research, 33 (2013), 5; 2043-2046

Podaci o odgovornosti

Šantak, Goran ; Šantak, Maja ; Forčić, Dubravko

engleski

Comparison of Antitumor Effects of Native and Recombinant Human Interferon-α on Non-small Cell Lung Cancer Cells

In the present work, we compared the antitumor effects of native human interferon-α (IFN-α) (nHuIFN-α) and recombinant human IFN-α (rHuIFN-α) on human lung adenocarcinoma A549 cells. The antitumor activity was determined by measuring cell viability and apoptosis, while the abundance of mRNA, measured by polymerase chain reaction (PCR), determined the potential role of p21 and survivin in antitumor activity of nHuIFN-α. The results show that nHuIFN-α significantly reduced A549 cell viability, compared to rHuIFN-α. The most potent effect of nHuIFN-α was also observed when apoptosis was measured. A549 cells treated with nHuIFN-α expressed a significantly higher amount of p21 mRNA, while the amount of survivin mRNA was significantly reduced. Considering both the anti-proliferative and anti- apoptotic effects of each IFN-α, we conclude that further elucidation of the mechanisms of the antitumor activity of nHuIFN-α will help in producing more effective and less toxic therapeutic protocols and preparations.

native human interferon alpha; recombinant human interferon alpha; non-small cell lung cancer; tumor proliferation; apoptosis; p21; survivin.

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

33 (5)

2013.

2043-2046

objavljeno

0250-7005

Povezanost rada

Temeljne medicinske znanosti, Kliničke medicinske znanosti, Biologija

Indeksiranost